Mostafa Faisal, Adjunct Assistant Professor at Alfaisal University, shared a post on X:
“A randomized, multicenter Phase II trial to compare prophylaxis of graft versus host disease with tacrolimus and mycophenolate mofetil versus ruxolitinib after post-transplant cyclophosphamide.”
Title: A randomized, multicenter Phase II trial to compare prophylaxis of graft versus host disease with tacrolimus and mycophenolate mofetil versus ruxolitinib after post-transplant cyclophosphamide
Authors: Moiseev I., Drokov M., Kitaeva Yu., Zhogolev D., Rudakova T., Barabanshchikova M., Chernyshova D., Bondarenko S., Kuzmina L., Rodionov G., Svetkina E., Lapin S., Kholopova I., Morozova E., Vasilyeva V., Vlasova Yu., Konstantinova T., Parovichnikova E., Kulagin A.
Read The Full Article
Other articles featuring Mostafa Faisal on OncoDaily.